Eliane de Fatima Duarte

Idiomas

Áreas de atuação

Participação em eventos

Produções bibliográficas

• DUARTE EC ; BIERRENBACH AL ; SILVA JR JB ; TAUIL PL ; DUARTE, E. . Factors associated with mortality of patients with pulmonary tuberculosis: a case-control study in Brazil. Journal of Epidemiology and Community Health , v. 63, p. 233-238, 2009.

• DERCHAIN, S. ; DUARTE, E. ; SArian, L.O. . Panorama atual e perspectivas em relação ao diagnostico precoce de câncer de ovário.. RBGO. Revista Brasileira de Ginecologia e Obstetrícia , v. 31, p. 1-10, 2009.

• ADES S ; KOUSHIK A ; DUARTE, E. ; et al . Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia. International Journal of Cancer , v. 122, p. 2820-2826, 2008.

• FRANCO E ; DUARTE, E. . Ovarian cancer and oral contraceptives. The Lancet (North American ed.) , v. 371, p. 277-278, 2008.

• MAYRAND MH ; DUARTE, E. . Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer. New England Journal of Medicine , v. 358, p. 641-644, 2007.

• STEBEN M ; DUARTE, E. . Human Papillomavirus Infection: Epidemiology and Pathophysiology. Gynecologic Oncology , v. 107, p. S2-S5, 2007.

• KROPP RY ; SEVIGNY C ; WONG T ; STEBEN M ; DUARTE, E. . The 2006 edition of the Canadian Guidelines on STIs: What s new?. Canadian Family Physician , v. 53, p. 1739-1741, 2007.

• MAHMUD SM ; AKOUSHIK ; DUARTE, E. ; et al . Haptoglobin phenotype and risk of cervical neoplasia: a case-control study. Clinica Chimica Acta , v. 385, p. 67-72, 2007.

• SICHERO L ; TROTTIER H ; DUARTE, E. ; et al . Re:Human papillomavirus type 16 and 18 variants: race-related distribution and persistence.. Journal of the National Cancer Institute , v. 99, p. 653-654, 2007.

• SCHAFFER A ; KOUSHIK A ; TROTTIER H ; DUARTE, E. ; et al . Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia.. Cancer Epidemiology, Biomarkers & Prevention , v. 16, p. 716-722, 2007.

• SICHERO L ; TROTTIER H ; DUARTE, E. ; et al . High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. International Journal of Cancer , v. 120, p. 1763-1768, 2007.

• SIEGEL E ; CRAFT N ; DUARTE, E. ; et al . Associations between serum carotenoids and tocopherols and type-specific HPV persistence and clearance: the Ludwig-McGill Cohort Study. International Journal of Cancer , v. 120, p. 672-680, 2007.

• SCHLECHT NE ; TREVISAN A ; BAGGIO ML ; GALAN L ; DUARTE, E. ; et al . Human papillomavirus infection and viral load correlates of agreement between cervicography and cytology. Journal of Lower Genital Tract Disease , v. 10, p. 229-237, 2006.

• TROTTIER H ; MAHMUD SM ; DUARTE, E. ; et al . Human papillomavirus infections with multiple types and risk of cervical neoplasia.. Cancer Epidemiology, Biomarkers & Prevention , v. 15, p. 1274-1280, 2006.

• MAYRAND MH ; DUARTE, E. ; et al . Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian Cervical Cancer Screening Trial (CCCaST).. International Journal of Cancer , v. 119, p. 615-623, 2006.

• KOUSHIK A ; GHOSH A ; DUARTE, E. ; et al . The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia.. Cancer Detection and Prevention , v. 29, p. 307-316, 2005.

• SIEGEL EM ; CRAFT NE ; ROE DJ ; DUARTE, E. ; et al . Temporal variation and identification of factors associated with endogenous retinoic acid isomers in serum from Brazilian women.. Cancer Epidemiology, Biomarkers & Prevention , v. 13, p. 1693-1703, 2004.

• FRANCO E ; DUARTE, E. . Screening every three years, instead of annually, would result in a small increase in risk of cervical cancer - Commentary. Evidence-Based Obstetrics and Gynecology , v. 6, p. 204-205, 2004.

• GIULIANO A ; SIEGEL E ; ROE DJ ; FERREIRA S ; BAGGIO ML ; GALAN L ; DUARTE, E. ; et al . Dietary intake and risk of persistent human papillomavirus (HPV) infection: The Ludwig-McGill HPV natural history study.. The Journal of Infectious Diseases , v. 15, p. 1508-1516, 2003.

• SCHLECHT NE ; PLATT RW ; NEGASSA A ; DUARTE, E. ; et al . Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions. American Journal of Epidemiology , v. 158, p. 878-886, 2003.

• SCHLECHT NE ; PLATT RW ; DUARTE, E. ; et al . Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.. Journal of the National Cancer Institute , v. 95, p. 1336-1343, 2003.

• SCHLECHT NE ; TREVISAN A ; DUARTE, E. ; et al . Viral load as a predictor of risk of cervical intraepithelial neoplasia.. International Journal of Cancer , v. 103, p. 519-524, 2003.

• TRAN-THANH D ; PROVENCHER D ; KOUSHIK A ; DUARTE, E. ; et al . Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix.. American Journal of Obstetrics and Gynecology , v. 188, p. 129-134, 2003.

• FRANCO E ; DUARTE, E. ; FERENCZY A . Prospects for controlling cervical cancer at the turn of the century.. Salud Pública de México , v. 45, p. S367-S375, 2003.

• FRANCO E ; DUARTE, E. ; ROHAN TE . Evidence-based policy recommendations on cancer screening and prevention. Cancer Detection and Prevention , v. 26, p. 350-361, 2002.

• STEINERT Y ; NASMITH L ; DAIGLE N ; DUARTE, E. . Improving teachers' skills in working with 'problem' residents: a workshop description and evaluation. Medical Teacher , v. 23, p. 284-288, 2001.

• SCHLECHT NE ; KULAGA S ; ROBITAILLE J ; FERREIRA S ; SANTOS M ; MIYAMURA RA ; DUARTE, E. ; et al . Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.. Journal of the American Medical Association , v. 286, p. 3106-3114, 2001.

• DUARTE, E. ; FRANCO E . Determinants of patient survival in cervical cancer: an overview. Gynecologic Oncology , v. 6, p. 173-183, 2001.

• FRANCO E ; DUARTE, E. ; FERENCZY A . Reply to E Ellison: Re: The merits of new alternatives to the Papanicolaou test.. CMAJ. Canadian Medical Association Journal , v. 165, p. 739-740, 2001.

• FRANCO E ; DUARTE, E. ; FERENCZY A . Cervical cancer: epidemiology, prevention and role of human papillomavirus infection. CMAJ. Canadian Medical Association Journal , v. 164, p. 1017-1025, 2001.

• DUARTE, E. ; FRANCO E . Epidemiologia do cancer mamario e ginecologico.. In: ABRAO F. (Org.). Tratado de oncologia genital e mamaria.. 2aed.São Paulo: Editora Roca, 2006, v. , p. -.

• DUARTE, E. ; FRANCO E . Câncer de anus: Epidemiologia e fatores de risco.. In: Rossi BM; Nakagawa WT; Ferreira FO; Aguiar S; Lopes A. (Org.). Câncer de Cólon, Reto e Anus. São Paulo: Editora Lemar andTecmedd, 2005, v. , p. 665-678.

• DUARTE, E. ; FRANCO E . Epidemiologia e fatores de risco do câncer colorretal. In: Rossi BM; Nakagawa WT; Ferreira FO; Aguiar S; Lopes A. (Org.). Câncer de Cólon, Reto e Anus.. São Paulo: Editora Lemar and Tecmedd, 2005, v. , p. 3-22.

• DUARTE, E. ; FRANCO E . Other Gynecological Cancers : endometrial, ovarian, vulvar and vaginal cancers. In: Health Canada. (Org.). Women's Health Surveillance Report. Montreal: Health Canada, 2004, v. , p. -.

• DUARTE, E. ; FRANCO E . Cancer of the Uterine Cervix.. In: Health Canada. (Org.). Women's Health Surveillance Report. Montreal: Health Canada, 2004, v. , p. -.

• DUARTE, E. ; et al . Preventing HPV infection by a vaccine against a sexually transmitted infection and many gynecological cancers.. Canadian Physiotherapy Association WHD Newsletter, Montreal, Canadá, p. 1 - 6, 30 jun. 2007.

• DUARTE, E. . Aspirin use and protection against cancer.. Facts & Stats in Cancer Prevention- Cancer Research Society.

• DUARTE, E. . Obesity: a cause of cancer in Europe.. Facts & Stats in Cancer Prevention - Cancer Research Society..

• DUARTE, E. ; et al . VIN-MONIQ: vulvar intraepithelial neoplasia (VIN) monitoring in Québec: estimate of burden of disease in the province of Quebec. 2009. (Apresentação de Trabalho/Congresso).

• STEBEN M ; DUARTE, E. ; et al . HPV genotyping in archived specimens of anal cancer diagnosed during one decade in Quebec (1995-2005). 2009. (Apresentação de Trabalho/Congresso).

• LOUCHINI R ; GOGGIN P ; DUARTE, E. ; STEBEN M . High anal cancer risk in individuals treated for anal condylomas in the province of Québec (Canada), from 1990 to 1999. 2008. (Apresentação de Trabalho/Congresso).

• LOUCHINI R ; GOGGIN P ; DUARTE, E. ; et al . High anal cancer risk in individuals treated for anal condylomas in the province of Québec (Canada), from 1990 to 1999.. 2008. (Apresentação de Trabalho/Congresso).

• MAYRAND MH ; DUARTE, E. ; et al . Insights from the longitudinal component of the Canadian Cervical Cancer Screening Trial (CCCAST). 2008. (Apresentação de Trabalho/Congresso).

• DUARTE, E. ; et al . VIN-MONIQ: vulvar intraepithelial neoplasia (VIN) monitoring in Québec: surveillance, clinical epidemiology, biomarkers, and quality of life. 2008. (Apresentação de Trabalho/Congresso).

• SIEGEL E ; LU B ; CRAFT NE ; DUARTE, E. ; et al . Circulating Antioxidant Nutrients Predictors of HPV viral load over time. 2007. (Apresentação de Trabalho/Congresso).

• ROSBERGER Z ; DIDIO P ; ROSEN N ; KNAUPER B ; MORRISON E ; TABING R. ; KRAWCZYK A ; MAYRAND MH ; DUARTE, E. ; et al . Age Differences in Knowledge and Attitudes about HPV and Cervical Cancer Risk.. 2007. (Apresentação de Trabalho/Congresso).

• TROTTIER H ; DUARTE, E. ; et al . HPV Infection, Cervical Neoplasia and Contraceptive Methods.. 2007. (Apresentação de Trabalho/Congresso).

• LOUCHINI R ; CHATEAU-DEGAT ML ; BRASSARD P ; DEMERS A ; DUARTE, E. ; et al . Prevalence 0f Cervical Intraepithelial Neoplasia and Cervical Cancer among Inuit Women in 2005, in Nunavik, Quebec, Canada. 2007. (Apresentação de Trabalho/Congresso).

• STEBEN M ; DUARTE, E. ; et al . Prevalence of the various HPV genotypes in archived specimens and risk factors of anal cancer reported in Québec (1995 2005). 2007. (Apresentação de Trabalho/Congresso).

• DUARTE, E. . Programme d éducation des patients et support de communication.. 2007. (Apresentação de Trabalho/Congresso).

• MAYRAND MH ; TROTTIER H ; DUARTE, E. ; et al . Modelling the Sensitivity and Specificity of Pap and HPV DNA Testing in Screening for Cervical Cancer Precursors: Results from the CCCaST Trial. 2007. (Apresentação de Trabalho/Congresso).

• DUARTE, E. ; et al . Prevalence of the various HPV genotypes in archived specimens and risk factors of anal cancer reported in Québec (1995 2005).. 2007. (Apresentação de Trabalho/Congresso).

• DUARTE, E. ; et al . DOVE: Detecting ovarian cancer earlier - a three phase multicentre study.. 2006. (Apresentação de Trabalho/Congresso).

• DUARTE, E. ; et al . DOVE: Detecting ovarian cancer earlier - a meta-analysis to produce a triage tool for symptoms and signs (S&S) suggestive of OC.. 2006. (Apresentação de Trabalho/Outra).

• TROTTIER H ; SCHAFFER A ; KOUSHIK A ; DUARTE, E. ; et al . Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia. 2006. (Apresentação de Trabalho/Congresso).

• MAYRAND MH ; DUARTE, E. ; et al . Comparison of Pap and HPV testing strategies for screening high-grade cervical cancer precursors: results from the Canadian Cervical Cancer Screening Trial (CCCAST). 2006. (Apresentação de Trabalho/Congresso).

• TREVISAN A ; SCHLECHT NE ; FERREIRA S ; SICHERO L ; FERENCZY A ; DUARTE, E. ; et al . Correlation Between Viral Load Mesured By Real-Time And Low-Stringency Pcr Testing Of Cervical Sspecimens. 2006. (Apresentação de Trabalho/Congresso).

• DUARTE, E. ; et al . DOVE: Detecting ovarian cancer earlier - Developing optimum assessment and fast-track referral for suspected ovarian malignancies. 2006. (Apresentação de Trabalho/Congresso).

• MAYRAND MH ; DUARTE, E. ; et al . Cross-sectional efficacy estimates of Pap vs HPV testing from the Canadian Cervical Cancer Screening Trial.. 2006. (Apresentação de Trabalho/Congresso).

• SIEGEL E ; CRAFT N ; ROE DJ ; DUARTE, E. ; et al . Temporal variation and identification of factors associated with endogenous retinoic acid isomers in serum from Brazilian women.. 2005. (Apresentação de Trabalho/Congresso).

• SPENCE A ; TROTTIER H ; DUARTE, E. ; et al . Cigarette Smoking, HPV Status, and Cervical Lesions: A Cumulative Case-Control Analysis using Repeated Measurements of Smoking and Viral and Lesion Status.. 2005. (Apresentação de Trabalho/Congresso).

• MAHMUD SM ; KOUSHIK A ; DUARTE, E. ; et al . Haptoglobin Phenotype and Risk of Cervical Neoplasia and HPV infection: A Case-Control Study.. 2005. (Apresentação de Trabalho/Congresso).

• MAYRAND MH ; DUARTE, E. ; et al . HPV vs Pap testing for screening cervical cancer and its high grade precursors: Preliminary efficacy data from the Canadian Cervical Cancer Screening Trial (CCCaST).. 2005. (Apresentação de Trabalho/Congresso).

• MAYRAND MH ; RODRIGUES I ; DUARTE, E. ; et al . HPV DNA detection with hybrid capture is more sensitive than pap testing for screening cervical cancer and its high grade precursors: preliminary results from the canadian cervical cancer screening trial (CCCAST).. 2005. (Apresentação de Trabalho/Seminário).

• DUARTE, E. ; et al . HPV testing versus Pap cytology in screening cervical cancer precursors: Design and baseline patient characteristics of The Canadian Cervical Cancer Screening Trial (CCCaST).. 2004. (Apresentação de Trabalho/Congresso).

• DUARTE, E. ; et al . Cervical inflammation as predictors of incident HPV infection in a long-term cohort study of women of screening age.. 2004. (Apresentação de Trabalho/Congresso).

• MAYRAND MH ; DUARTE, E. ; et al . HPV testing versus Pap cytology in screening cervical cancer precursors: Design and baseline patient characteristics of The Canadian Cervical Cancer Screening Trial (CCCaST).. 2004. (Apresentação de Trabalho/Congresso).

• SIEGEL E ; GIULIANO A ; CRAFT N ; FERREIRA S ; BAGGIO ML ; GALAN L ; DUARTE, E. ; et al . Circulating Antioxidant Nutrients and Clearance of HPV infection Among Women in the Ludwig-McGill Natural History Cohort. 2004. (Apresentação de Trabalho/Congresso).

• SIEGEL E ; CRAFT N ; FERREIRA S ; BAGGIO ML ; GALAN L ; DUARTE, E. ; et al . Effect of endogenous retinoic acid on type-specific HPV clearance in women participating in the Ludwig-McGill HPV Natural History Cohort. 2004. (Apresentação de Trabalho/Congresso).

• DUARTE, E. ; et al . HPV testing vs Pap cytology in screening cervical cancer precursors: The Canadian cervical cancer screening trial.. 2004. (Apresentação de Trabalho/Congresso).

• RODRIGUES I ; MAYRAND MH ; DUARTE, E. ; et al . HPV testing vs Pap cytology in screening cervical cancer precursors: The Canadian cervical cancer screening trial (CCCaST. 2003. (Apresentação de Trabalho/Seminário).

• DUARTE, E. ; et al . The cervical cancer screening trial: HPV testing vs Pap cytology in screening cervical cancer precursors. 2003. (Apresentação de Trabalho/Congresso).

• RATNAM S ; FRANCO E ; DUARTE, E. ; et al . HPV testing in primary cervical cancer screening: A Canadian experience. 2003. (Apresentação de Trabalho/Congresso).

• MAYRAND MH ; DUARTE, E. ; et al . HPV testing vs Pap cytology in screening cervical cancer precursors: The cervical cancer screening trial. 2003. (Apresentação de Trabalho/Seminário).

• SPENCE A ; DUARTE, E. ; et al . Pap cytology screening failure: Influences of the patient, physician and laboratory.. 2003. (Apresentação de Trabalho/Congresso).

Projetos de pesquisa

• 2010 - 2010

  Impacto das legislacoes locais de controle do tabagismo em lugares publicos nas doencas cardiovasculares, Situação: Em andamento; Natureza: Pesquisa. , Integrantes: Eliane de Fatima Duarte - Integrante / Deborah Carvalho Malta - Coordenador / Sara Mirza - Integrante / Ben APELBERG - Integrante.

• 2009 - 2009

  A population-based innovative approach to measuring the burden of HPV-related diseases., Descrição: Metodo inovador de se mesurar em base populacional a prevalencia de doencas relacionadas ao virus do papiloma humano.. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Eliane de Fatima Duarte - Integrante / GOGGIN P - Coordenador / Francois Coutlee - Integrante / France Lavoie - Integrante / Eve Dubee - Integrante / Vladimir Gilca - Integrante., Financiador(es): Ministere de la sante et des services sociaux du Quebec - Auxílio financeiro / Public Health Agency of Canada - Auxílio financeiro.

• 2007 - 2009

  Prevalence of the various HPV genotypes in archived specimens and risk factors of anal cancer reported in Québec (1995 2005)., Descrição: Prevalencia dos varios genotipos de VPH in especimens arquivados e fatores de risco do cancer anal em Quebec (1995 2005).. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Eliane de Fatima Duarte - Integrante / GOGGIN P - Integrante / Francois Coutlee - Integrante / Marc Steben - Coordenador / Rachid Hadjeres - Integrante / Caroline Rodier - Integrante.

• 2007 - 2009

  Management of vulvar and vaginal cancers and its precursor lesions: a practice survey of Quebec gynecologists, dermatologists and pathologists., Descrição: Diagnostico e tratamento de pacientes com cancer de vagina e vulva e suas lesoes precursoras: uma enquete junto a ginecologistas, dermatologistas e patologistas na provincia de Quebec.. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Eliane de Fatima Duarte - Integrante / Francois Coutlee - Integrante / Marc Steben - Coordenador / Rachid Hadjeres - Integrante / Caroline Rodier - Integrante / John S Sampalis - Integrante / Marie Claude Renaud - Integrante / Philip Sauthier - Integrante / Sophie Bergeron - Integrante / Alex Ferenczy - Integrante / Patricia Goggin - Integrante / James Mansi - Integrante., Financiador(es): Merck-Frosst International - Auxílio financeiro.

Prêmios